Transgene

Stocks

Market Closed - Euronext Paris 01:55:00 27/08/26 am AEST			5-day change	1st Jan Change
0.8110 ^EUR	+0.62%		-3.45%	-15.52%

30/06	Transgene SA - Special Call
25/06	Oddo BHF Stays Positive on Transgene

Published on 06/30/2026 at 12:35 am AEST - Modified on 06/30/2026 at 06:52 am AEST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Good morning, and welcome to the Transgene virtual key opinion leader event. At this time, all attendees are in a listen-only mode and a

[

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Unlimited browsing across the entire site

Access to all news and data

US, Europe, and Asia portfolios

Ad-free reading

Pro Tools : expert screeners, historical financials, PDF reports, investment themes, and earnings transcripts

30/06	Transgene SA - Special Call
25/06	Oddo BHF Stays Positive on Transgene
25/06	Positive Preclinical Data for a Transgene Vaccine
25/06	Transgene Presents Preclinical Data Demonstrating Robust Protection Against Mpox With Its Novel Scalable Cell Line?Derived MVA Vaccine Candidate TG-MVATM	CI
22/06	Transgene Expands myvac® into Non-Small Cell Lung Cancer with TG4070, an Individualized Neoantigen Therapeutic Vaccine	CI
22/06	Transgene launches a clinical trial evaluating TG4070 with nivolumab
22/06	Transgene Begins Phase 1 Trial of Non-small Cell Lung Cancer Vaccine	MT
23/05	Transgene SA Announces Board Appointments	CI
13/04	Transgene Completes Patient Randomization in Phase 2 Clinical Trial Evaluating TG4050 in Adjuvant Treatment of Head and Neck Cancer	CI
07/04	Transgene stands out following licensing agreement with NEC Bio
03/04	Transgene, NEC Bio Enter Partnership to Develop Cancer Vaccine	MT
03/04	Transgene and NEC Bio Sign License Agreement for TG4050 Development in Head and Neck Cancer	CI
03/04	Transgene & NEC Bio sign license agreement to prepare next steps of development of TG4050 in head & neck cancer	RE
25/03	Danone, Dassault Systèmes, Orange... stocks to watch today in Paris
25/03	Transgene SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI